HomeInsightsStock Comparison

Cipla Ltd vs Sai Life Sciences Ltd Stock Comparison

Cipla Ltd vs Sai Life Sciences Ltd Stock Comparison

Last Updated on: Jul 08, 2025

Key Highlights

  • The Latest Trading Price of Cipla Ltd is ₹ 1491 as of 08 Jul 10:21.
  • The P/E Ratio of Cipla Ltd changed from 22 on March 2020 to 22.1 on March 2025 . This represents a CAGR of 0.08% over 6 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Cipla Ltd changed from ₹ 34103 crore on March 2020 to ₹ 116434 crore on March 2025 . This represents a CAGR of 22.71% over 6 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Cipla Ltd for the Mar '25 is ₹ 7019 crore as compare to the Dec '24 revenue of ₹ 7294 crore. This represent the decline of -3.78% The revenue of Sai Life Sciences Ltd for the Mar '25 is ₹ 589.11 crore as compare to the Dec '24 revenue of ₹ 448.89 crore. This represent the growth of 31.24%.
  • The ebitda of Cipla Ltd for the Mar '25 is ₹ 1827 crore as compare to the Dec '24 ebitda of ₹ 2210 crore. This represent the decline of -17.35% The ebitda of Sai Life Sciences Ltd for the Mar '25 is ₹ 167.17 crore as compare to the Dec '24 ebitda of ₹ 128.87 crore. This represent the growth of 29.72%.
  • The net profit of Cipla Ltd changed from ₹ 996.58 crore to ₹ 1225 crore over 8 quarters. This represents a CAGR of 10.87% The net profit of Sai Life Sciences Ltd changed from ₹ 39.61 crore to ₹ 88.27 crore over 6 quarters. This represents a CAGR of 70.61% .
  • The Dividend Payout of Cipla Ltd changed from 14.24 % on March 2020 to 25.05 % on March 2025 . This represents a CAGR of 9.87% over 6 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Cipla Ltd

  • Cipla Limited is one of the leading pharmaceutical companies in India.
  • The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
  • Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
  • With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
  • Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

About Sai Life Sciences Ltd

  • Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
  • Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
  • Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

Cipla Ltd News Hub

News

Cipla to conduct board meeting

Cipla will hold a meeting of the Board of Directors of the Company on 25 July 2025. Powere...

Read more

02 Jul 2025 10:19

News

Cipla allots 43,396 equity shares under ESOP

Cipla has allotted 43,396 fully paid-up equity shares of Rs 2 each, pursuant to exercise o...

Read more

27 Jun 2025 11:02

News

Cipla Ltd spurts 0.42%, up for fifth straight session

Cipla Ltd is up for a fifth straight session today. The stock is quoting at Rs 1517.2, up ...

Read more

11 Jun 2025 13:00

News

Jay Precision Pharmaceuticals acquires 26% stake in AMPIN Energy C&I Eighteen

Jay Precision Pharmaceuticals, subsidiary of Cipla, has completed acquisition of 26% stake...

Read more

29 May 2025 18:48

News

Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany

Cipla announced that Cipla (EU), UK, a wholly owned subsidiary of the Company, has incorpo...

Read more

29 May 2025 18:50

News

Cipla to convene AGM

Cipla announced that the 89th Annual General Meeting(AGM) of the company will be held on 1...

Read more

14 May 2025 15:08

Sai Life Sciences Ltd News Hub

News

Sai Life Sciences rises on completion of second phase expansion at Bidar facility

The new phase, which became operational on 19 June 2025, adds approximately 91 kL of produ...

Read more

20 Jun 2025 14:49

News

Board of Sai Life Sciences approves allotment of 19,000 equity shares under EOSP

The Board of Sai Life Sciences at its meeting held on 09 June 2025 has approved and allott...

Read more

09 Jun 2025 19:33

News

Sai Life Sciences allots 25,000 equity shares under ESOPs

Sai Life Sciences has allotted 25,000 equity shares under ESOPs on 13 May 2025. Powered by...

Read more

14 May 2025 09:28

News

Sai Life Sciences jumps after stellar results

EBITDA jumped 42% year-on-year (YoY) to Rs 425 crore in FY25. EBITDA margin improved to 25...

Read more

14 May 2025 16:16

News

Sai Life Sciences to announce Quarterly Result

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May 2...

Read more

08 May 2025 11:19

News

Sai Life Sciences schedules board meeting

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May 2...

Read more

07 May 2025 11:31

SWOT Analysis Of Cipla Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sai Life Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Cipla Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Cipla Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Cipla Ltd or Sai Life Sciences Ltd?

Market cap of Cipla Ltd is 122,032 Cr while Market cap of Sai Life Sciences Ltd is 16,564 Cr

What are the key factors driving the stock performance of Cipla Ltd and Sai Life Sciences Ltd?

The stock performance of Cipla Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cipla Ltd and Sai Life Sciences Ltd?

As of July 8, 2025, the Cipla Ltd stock price is INR ₹1510.85. On the other hand, Sai Life Sciences Ltd stock price is INR ₹793.5.

How do dividend payouts of Cipla Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Cipla Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions